Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Schnell Biopharmaceuticals,Inc. Announces Change of CEO


Monday, 23 Sep 2013 03:03am EDT 

Schnell Biopharmaceuticals,Inc. announced the change of Chief Executive Officer from Kim Jae Seop to Kim Jeong Chul, effective September 23, 2013. 

Company Quote

451.0
16.0 +3.68%
1 Aug 2014